Candida spp. | Antifungals (μg/mL) | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ampho B | Micafungin | Caspofungin | |||||||||||||
n | Range | MIC50 | MIC90 | Range | MIC50 | MIC90 | Range | MIC50 | MIC90 | ||||||
(B) | |||||||||||||||
Candida sphaerica | 0.015–0.0312 | ND | ND | < 0.0156–0.5 | ND | ND | 0.12–0.5 | ND | ND | 0.015–0.031 | ND | ND | |||
Candida zeylanoides | 0.015–0.03 | ND | ND | 0.015–0.03 | ND | ND | 4–Feb | ND | ND | 0.06–0.25 | ND | ND | |||
Candida lusitaniae | 0.015–0.6 | 0.031 | 0.063 | 0.015–0.6 | 0.031 | 0.063 | 0.125–32 | 2 | 6 | 0.015–0.6 | 0.031 | 0.047 | |||
Candida utilis | 0.015–0.6 | ND | ND | 0.015–0.6 | ND | ND | 0.5–4 | ND | ND | 0.015–0.3 | ND | ND | |||
Candida Guilliermondii | 0.25–2 | 0.5 | 1 | 0.032–0.13 | 0.03 | 0.06 | 0.75–1.5 | 0.89 | 1 | 0.032–0.13 | 0.03 | 0.06 | |||
Candida thermophila | 0.015–0.31 | ND | ND | 0.015–0.31 | ND | ND | 0.5–1 | ND | ND | 0.015–0.31 | ND | ND | |||
Other Candida | 0.015–0.31 | ND | ND | 0.015–0.31 | ND | ND | 0.015–0.31 | ND | ND | 0.015–0.31 | ND | ND |
IE, Insufficient Evidence that the organism or group is a good target for therapy with the agent, ND, Not Determined (for statistical significance purposes, MIC90 was not determined when the number of isolates was lower than 10.